curved periodic phase grating g1 Search Results


95
Genovis Inc sialexo
Sialexo, supplied by Genovis Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sialexo/product/Genovis Inc
Average 95 stars, based on 1 article reviews
sialexo - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

95
Bio-Techne corporation g1 results
G1 Results, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g1 results/product/Bio-Techne corporation
Average 95 stars, based on 1 article reviews
g1 results - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

95
Tocris gper agonist g1
Gper Agonist G1, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gper agonist g1/product/Tocris
Average 95 stars, based on 1 article reviews
gper agonist g1 - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

90
Becton Dickinson 27 g 1/2 18 g1 1/2 needles
27 G 1/2 18 G1 1/2 Needles, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/27 g 1/2 18 g1 1/2 needles/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
27 g 1/2 18 g1 1/2 needles - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

91
BOC Sciences 201 hcv g1 prior relapsers
201 Hcv G1 Prior Relapsers, supplied by BOC Sciences, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/201 hcv g1 prior relapsers/product/BOC Sciences
Average 91 stars, based on 1 article reviews
201 hcv g1 prior relapsers - by Bioz Stars, 2026-06
91/100 stars
  Buy from Supplier

93
Selleck Chemicals g1 arrest
Nek2-dependent release of DAs is independent of Plk1. (A) RPE1 expressing mNeonGreen-Nek2A (Nek2-WT) or mNeonGreen-Nek2A-KD mutant (Nek2A-KD) under control of the DOX-inducible promoter were treated with solvent only (− DOX) or DOX (+ DOX) in the presence or absence of the <t>Plk1</t> <t>inhibitor</t> BI-2536. Cells were analyzed using anti-Cep164 antibodies. Boxplots show the quantification of Cep164 signal at the centrosome after normalization to the − DOX − BI-2536 control. Boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. Data from three independent experiments are shown. n = 250 cells per condition. (B) Percentage of prometaphase cells for experiment shown in A was quantified as a control for Plk1 inhibition . n = 70 cells per condition. (C) Box/dot plots show the normalized intensities of the indicated proteins in RPE1 cells carrying the hyperactive mutant PLK1-T210D under control of the DOX-inducible promoter. Cells were treated with solvent (− DOX) or DOX (+ DOX). Dots represent individual cells, boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. The graphs show the data from three independent experiments. n = 50 cells were analyzed per condition and experiment. Western blot shows the levels of PLK1-mNeonGreen ± DOX. Actin was used as a loading control. (D) Images show the signal of the indicated DAs (red) in RPE1 cells without (− DOX) or with (+ DOX) overexpression of mNeonGreen-PLK1-T210D. The insets represent magnification of the centrosome area. Scale bar, 10 µm. γ-tub, γ-tubulin. (E) Schematic diagram of the experimental procedure and quantification of the average of cells in <t>G1</t> phase in three independent experiments analyzed by FACS ( n = 37,487 cells). Graph shows a representative FACS plot for propidium iodide detection area (488-D-A). (F) RPE1 mNeonGreen-Nek2A–expressing cells were treated as described in E, and the indicated protein intensities at the centrosome were quantified. Dots represent individual cells, boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. n = 150 cells per condition and protein in three independent experiments. γ-tubulin and DAPI serve as markers for centrosomes and nuclei, respectively. A.U., arbitrary units; n.s., not significant. Significance probability values are: n.s., P > 0.05; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001.
G1 Arrest, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g1 arrest/product/Selleck Chemicals
Average 93 stars, based on 1 article reviews
g1 arrest - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

93
R&D Systems human aggrecan g1 igd g2 domains
Nek2-dependent release of DAs is independent of Plk1. (A) RPE1 expressing mNeonGreen-Nek2A (Nek2-WT) or mNeonGreen-Nek2A-KD mutant (Nek2A-KD) under control of the DOX-inducible promoter were treated with solvent only (− DOX) or DOX (+ DOX) in the presence or absence of the <t>Plk1</t> <t>inhibitor</t> BI-2536. Cells were analyzed using anti-Cep164 antibodies. Boxplots show the quantification of Cep164 signal at the centrosome after normalization to the − DOX − BI-2536 control. Boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. Data from three independent experiments are shown. n = 250 cells per condition. (B) Percentage of prometaphase cells for experiment shown in A was quantified as a control for Plk1 inhibition . n = 70 cells per condition. (C) Box/dot plots show the normalized intensities of the indicated proteins in RPE1 cells carrying the hyperactive mutant PLK1-T210D under control of the DOX-inducible promoter. Cells were treated with solvent (− DOX) or DOX (+ DOX). Dots represent individual cells, boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. The graphs show the data from three independent experiments. n = 50 cells were analyzed per condition and experiment. Western blot shows the levels of PLK1-mNeonGreen ± DOX. Actin was used as a loading control. (D) Images show the signal of the indicated DAs (red) in RPE1 cells without (− DOX) or with (+ DOX) overexpression of mNeonGreen-PLK1-T210D. The insets represent magnification of the centrosome area. Scale bar, 10 µm. γ-tub, γ-tubulin. (E) Schematic diagram of the experimental procedure and quantification of the average of cells in <t>G1</t> phase in three independent experiments analyzed by FACS ( n = 37,487 cells). Graph shows a representative FACS plot for propidium iodide detection area (488-D-A). (F) RPE1 mNeonGreen-Nek2A–expressing cells were treated as described in E, and the indicated protein intensities at the centrosome were quantified. Dots represent individual cells, boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. n = 150 cells per condition and protein in three independent experiments. γ-tubulin and DAPI serve as markers for centrosomes and nuclei, respectively. A.U., arbitrary units; n.s., not significant. Significance probability values are: n.s., P > 0.05; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001.
Human Aggrecan G1 Igd G2 Domains, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human aggrecan g1 igd g2 domains/product/R&D Systems
Average 93 stars, based on 1 article reviews
human aggrecan g1 igd g2 domains - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

96
R&D Systems isotype control serum
Nek2-dependent release of DAs is independent of Plk1. (A) RPE1 expressing mNeonGreen-Nek2A (Nek2-WT) or mNeonGreen-Nek2A-KD mutant (Nek2A-KD) under control of the DOX-inducible promoter were treated with solvent only (− DOX) or DOX (+ DOX) in the presence or absence of the <t>Plk1</t> <t>inhibitor</t> BI-2536. Cells were analyzed using anti-Cep164 antibodies. Boxplots show the quantification of Cep164 signal at the centrosome after normalization to the − DOX − BI-2536 control. Boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. Data from three independent experiments are shown. n = 250 cells per condition. (B) Percentage of prometaphase cells for experiment shown in A was quantified as a control for Plk1 inhibition . n = 70 cells per condition. (C) Box/dot plots show the normalized intensities of the indicated proteins in RPE1 cells carrying the hyperactive mutant PLK1-T210D under control of the DOX-inducible promoter. Cells were treated with solvent (− DOX) or DOX (+ DOX). Dots represent individual cells, boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. The graphs show the data from three independent experiments. n = 50 cells were analyzed per condition and experiment. Western blot shows the levels of PLK1-mNeonGreen ± DOX. Actin was used as a loading control. (D) Images show the signal of the indicated DAs (red) in RPE1 cells without (− DOX) or with (+ DOX) overexpression of mNeonGreen-PLK1-T210D. The insets represent magnification of the centrosome area. Scale bar, 10 µm. γ-tub, γ-tubulin. (E) Schematic diagram of the experimental procedure and quantification of the average of cells in <t>G1</t> phase in three independent experiments analyzed by FACS ( n = 37,487 cells). Graph shows a representative FACS plot for propidium iodide detection area (488-D-A). (F) RPE1 mNeonGreen-Nek2A–expressing cells were treated as described in E, and the indicated protein intensities at the centrosome were quantified. Dots represent individual cells, boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. n = 150 cells per condition and protein in three independent experiments. γ-tubulin and DAPI serve as markers for centrosomes and nuclei, respectively. A.U., arbitrary units; n.s., not significant. Significance probability values are: n.s., P > 0.05; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001.
Isotype Control Serum, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/isotype control serum/product/R&D Systems
Average 96 stars, based on 1 article reviews
isotype control serum - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

90
DestiNA Genomics Ltd destina- id node id
Nek2-dependent release of DAs is independent of Plk1. (A) RPE1 expressing mNeonGreen-Nek2A (Nek2-WT) or mNeonGreen-Nek2A-KD mutant (Nek2A-KD) under control of the DOX-inducible promoter were treated with solvent only (− DOX) or DOX (+ DOX) in the presence or absence of the <t>Plk1</t> <t>inhibitor</t> BI-2536. Cells were analyzed using anti-Cep164 antibodies. Boxplots show the quantification of Cep164 signal at the centrosome after normalization to the − DOX − BI-2536 control. Boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. Data from three independent experiments are shown. n = 250 cells per condition. (B) Percentage of prometaphase cells for experiment shown in A was quantified as a control for Plk1 inhibition . n = 70 cells per condition. (C) Box/dot plots show the normalized intensities of the indicated proteins in RPE1 cells carrying the hyperactive mutant PLK1-T210D under control of the DOX-inducible promoter. Cells were treated with solvent (− DOX) or DOX (+ DOX). Dots represent individual cells, boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. The graphs show the data from three independent experiments. n = 50 cells were analyzed per condition and experiment. Western blot shows the levels of PLK1-mNeonGreen ± DOX. Actin was used as a loading control. (D) Images show the signal of the indicated DAs (red) in RPE1 cells without (− DOX) or with (+ DOX) overexpression of mNeonGreen-PLK1-T210D. The insets represent magnification of the centrosome area. Scale bar, 10 µm. γ-tub, γ-tubulin. (E) Schematic diagram of the experimental procedure and quantification of the average of cells in <t>G1</t> phase in three independent experiments analyzed by FACS ( n = 37,487 cells). Graph shows a representative FACS plot for propidium iodide detection area (488-D-A). (F) RPE1 mNeonGreen-Nek2A–expressing cells were treated as described in E, and the indicated protein intensities at the centrosome were quantified. Dots represent individual cells, boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. n = 150 cells per condition and protein in three independent experiments. γ-tubulin and DAPI serve as markers for centrosomes and nuclei, respectively. A.U., arbitrary units; n.s., not significant. Significance probability values are: n.s., P > 0.05; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001.
Destina Id Node Id, supplied by DestiNA Genomics Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/destina- id node id/product/DestiNA Genomics Ltd
Average 90 stars, based on 1 article reviews
destina- id node id - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
GenScript corporation genes encoding nada, gna2091-fhbp-g1 and fhbp-g1-g1
Nek2-dependent release of DAs is independent of Plk1. (A) RPE1 expressing mNeonGreen-Nek2A (Nek2-WT) or mNeonGreen-Nek2A-KD mutant (Nek2A-KD) under control of the DOX-inducible promoter were treated with solvent only (− DOX) or DOX (+ DOX) in the presence or absence of the <t>Plk1</t> <t>inhibitor</t> BI-2536. Cells were analyzed using anti-Cep164 antibodies. Boxplots show the quantification of Cep164 signal at the centrosome after normalization to the − DOX − BI-2536 control. Boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. Data from three independent experiments are shown. n = 250 cells per condition. (B) Percentage of prometaphase cells for experiment shown in A was quantified as a control for Plk1 inhibition . n = 70 cells per condition. (C) Box/dot plots show the normalized intensities of the indicated proteins in RPE1 cells carrying the hyperactive mutant PLK1-T210D under control of the DOX-inducible promoter. Cells were treated with solvent (− DOX) or DOX (+ DOX). Dots represent individual cells, boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. The graphs show the data from three independent experiments. n = 50 cells were analyzed per condition and experiment. Western blot shows the levels of PLK1-mNeonGreen ± DOX. Actin was used as a loading control. (D) Images show the signal of the indicated DAs (red) in RPE1 cells without (− DOX) or with (+ DOX) overexpression of mNeonGreen-PLK1-T210D. The insets represent magnification of the centrosome area. Scale bar, 10 µm. γ-tub, γ-tubulin. (E) Schematic diagram of the experimental procedure and quantification of the average of cells in <t>G1</t> phase in three independent experiments analyzed by FACS ( n = 37,487 cells). Graph shows a representative FACS plot for propidium iodide detection area (488-D-A). (F) RPE1 mNeonGreen-Nek2A–expressing cells were treated as described in E, and the indicated protein intensities at the centrosome were quantified. Dots represent individual cells, boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. n = 150 cells per condition and protein in three independent experiments. γ-tubulin and DAPI serve as markers for centrosomes and nuclei, respectively. A.U., arbitrary units; n.s., not significant. Significance probability values are: n.s., P > 0.05; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001.
Genes Encoding Nada, Gna2091 Fhbp G1 And Fhbp G1 G1, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/genes encoding nada, gna2091-fhbp-g1 and fhbp-g1-g1/product/GenScript corporation
Average 90 stars, based on 1 article reviews
genes encoding nada, gna2091-fhbp-g1 and fhbp-g1-g1 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Fecpak International Limited fecpak g1
Repeatability of methods of equine faecal egg counting using the <t> FECPAK G1 </t> and FECPAK G2 . A repeated measures ANOVA (rmANOVA) was used to test the repeatability of the G1 and G2 methods on the faecal egg count (FEC) replicates of individual equine samples. The analysis demonstrates no differences between the repeated samples meaning that average FEC for each individual could be used to compare the G1 and G2 methods.
Fecpak G1, supplied by Fecpak International Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fecpak g1/product/Fecpak International Limited
Average 90 stars, based on 1 article reviews
fecpak g1 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Thermo Fisher mn03928990 g1
Repeatability of methods of equine faecal egg counting using the <t> FECPAK G1 </t> and FECPAK G2 . A repeated measures ANOVA (rmANOVA) was used to test the repeatability of the G1 and G2 methods on the faecal egg count (FEC) replicates of individual equine samples. The analysis demonstrates no differences between the repeated samples meaning that average FEC for each individual could be used to compare the G1 and G2 methods.
Mn03928990 G1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mn03928990 g1/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
mn03928990 g1 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Nek2-dependent release of DAs is independent of Plk1. (A) RPE1 expressing mNeonGreen-Nek2A (Nek2-WT) or mNeonGreen-Nek2A-KD mutant (Nek2A-KD) under control of the DOX-inducible promoter were treated with solvent only (− DOX) or DOX (+ DOX) in the presence or absence of the Plk1 inhibitor BI-2536. Cells were analyzed using anti-Cep164 antibodies. Boxplots show the quantification of Cep164 signal at the centrosome after normalization to the − DOX − BI-2536 control. Boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. Data from three independent experiments are shown. n = 250 cells per condition. (B) Percentage of prometaphase cells for experiment shown in A was quantified as a control for Plk1 inhibition . n = 70 cells per condition. (C) Box/dot plots show the normalized intensities of the indicated proteins in RPE1 cells carrying the hyperactive mutant PLK1-T210D under control of the DOX-inducible promoter. Cells were treated with solvent (− DOX) or DOX (+ DOX). Dots represent individual cells, boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. The graphs show the data from three independent experiments. n = 50 cells were analyzed per condition and experiment. Western blot shows the levels of PLK1-mNeonGreen ± DOX. Actin was used as a loading control. (D) Images show the signal of the indicated DAs (red) in RPE1 cells without (− DOX) or with (+ DOX) overexpression of mNeonGreen-PLK1-T210D. The insets represent magnification of the centrosome area. Scale bar, 10 µm. γ-tub, γ-tubulin. (E) Schematic diagram of the experimental procedure and quantification of the average of cells in G1 phase in three independent experiments analyzed by FACS ( n = 37,487 cells). Graph shows a representative FACS plot for propidium iodide detection area (488-D-A). (F) RPE1 mNeonGreen-Nek2A–expressing cells were treated as described in E, and the indicated protein intensities at the centrosome were quantified. Dots represent individual cells, boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. n = 150 cells per condition and protein in three independent experiments. γ-tubulin and DAPI serve as markers for centrosomes and nuclei, respectively. A.U., arbitrary units; n.s., not significant. Significance probability values are: n.s., P > 0.05; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001.

Journal: The Journal of Cell Biology

Article Title: Nek2 kinase displaces distal appendages from the mother centriole prior to mitosis

doi: 10.1083/jcb.201907136

Figure Lengend Snippet: Nek2-dependent release of DAs is independent of Plk1. (A) RPE1 expressing mNeonGreen-Nek2A (Nek2-WT) or mNeonGreen-Nek2A-KD mutant (Nek2A-KD) under control of the DOX-inducible promoter were treated with solvent only (− DOX) or DOX (+ DOX) in the presence or absence of the Plk1 inhibitor BI-2536. Cells were analyzed using anti-Cep164 antibodies. Boxplots show the quantification of Cep164 signal at the centrosome after normalization to the − DOX − BI-2536 control. Boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. Data from three independent experiments are shown. n = 250 cells per condition. (B) Percentage of prometaphase cells for experiment shown in A was quantified as a control for Plk1 inhibition . n = 70 cells per condition. (C) Box/dot plots show the normalized intensities of the indicated proteins in RPE1 cells carrying the hyperactive mutant PLK1-T210D under control of the DOX-inducible promoter. Cells were treated with solvent (− DOX) or DOX (+ DOX). Dots represent individual cells, boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. The graphs show the data from three independent experiments. n = 50 cells were analyzed per condition and experiment. Western blot shows the levels of PLK1-mNeonGreen ± DOX. Actin was used as a loading control. (D) Images show the signal of the indicated DAs (red) in RPE1 cells without (− DOX) or with (+ DOX) overexpression of mNeonGreen-PLK1-T210D. The insets represent magnification of the centrosome area. Scale bar, 10 µm. γ-tub, γ-tubulin. (E) Schematic diagram of the experimental procedure and quantification of the average of cells in G1 phase in three independent experiments analyzed by FACS ( n = 37,487 cells). Graph shows a representative FACS plot for propidium iodide detection area (488-D-A). (F) RPE1 mNeonGreen-Nek2A–expressing cells were treated as described in E, and the indicated protein intensities at the centrosome were quantified. Dots represent individual cells, boxes show interquartile range, lines inside the box represent the median, and whiskers show minimum and maximum values excluding outliers. n = 150 cells per condition and protein in three independent experiments. γ-tubulin and DAPI serve as markers for centrosomes and nuclei, respectively. A.U., arbitrary units; n.s., not significant. Significance probability values are: n.s., P > 0.05; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001.

Article Snippet: For G1 arrest, cells were treated with the Cdk4/6 inhibitor palbociclib (no. S1116; Selleckchem) at a concentration of 0.1 μM for 24 h and for an additional 24 h at a concentration of 1 μM as indicated in the respective figure legends.

Techniques: Expressing, Mutagenesis, Control, Solvent, Inhibition, Western Blot, Over Expression

Repeatability of methods of equine faecal egg counting using the  FECPAK G1  and FECPAK G2 . A repeated measures ANOVA (rmANOVA) was used to test the repeatability of the G1 and G2 methods on the faecal egg count (FEC) replicates of individual equine samples. The analysis demonstrates no differences between the repeated samples meaning that average FEC for each individual could be used to compare the G1 and G2 methods.

Journal: Animals : an Open Access Journal from MDPI

Article Title: Novel Equine Faecal Egg Diagnostics: Validation of the FECPAK G2

doi: 10.3390/ani10081254

Figure Lengend Snippet: Repeatability of methods of equine faecal egg counting using the FECPAK G1 and FECPAK G2 . A repeated measures ANOVA (rmANOVA) was used to test the repeatability of the G1 and G2 methods on the faecal egg count (FEC) replicates of individual equine samples. The analysis demonstrates no differences between the repeated samples meaning that average FEC for each individual could be used to compare the G1 and G2 methods.

Article Snippet: Therefore, the FECPAK G1 (G1) was chosen as a comparative FEC for validating future FEC systems not established for equine use.

Techniques: